Ha Tay Pharmaceutical

DHT

VN000000DHT3

Pharmaceuticals

End-of-day quote HANOI S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
40,400 ^VND	+2.80%		+10.99%	+75.65%

25/04	Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
22/01	Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2024

April 25, 2024 at 03:33 pm IST

Ha Tay Pharmaceutical JSC reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was VND 505,680.71 million compared to VND 499,233.35 million a year ago. Net income was VND 14,643.52 million compared to VND 26,392.94 million a year ago.

Latest news about Ha Tay Pharmaceutical

Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/01	CI
Ha Tay Pharmaceutical JSC announced that it has received VND 180.6 billion in funding from ASKA Pharmaceutical Holdings Co.,Ltd.	21/12	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	24/23/24	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/23/24	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/22/24	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	20/22/20	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2022	21/22/21	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	27/22/27	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Full Year Ended December 31, 2021	27/22/27	CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	20/21/20	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Second Quarter Ended June 30, 2021	21/21/21	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the First Quarter Ended March 31, 2021	22/21/22	CI
ASKA Pharmaceutical Co., Ltd. acquired additional 20% stake in Ha Tay Pharmaceutical JSC.	04/21/04	CI
ASKA Pharmaceutical Co., Ltd. completed the acquisition of 24.9% stake in Ha Tay Pharmaceutical JSC.	15/21/15	CI
Ha Tay Pharmaceutical JSC announced that it has received VND 369.70241 billion in funding from ASKA Pharmaceutical Co., Ltd.	15/21/15	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Third Quarter Ended September 30, 2020	20/20/20	CI
Ha Tay Pharmaceutical JSC announced that it expects to receive VND 369.70241 billion in funding from ASKA Pharmaceutical Co., Ltd. and other investors	14/20/14	CI
ASKA Pharmaceutical Co., Ltd. signed an agreement to acquire 24.9% stake in Ha Tay Pharmaceutical JSC.	18/20/18	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Second Quarter Ended June 30, 2020	20/20/20	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the First Quarter Ended March 31, 2020	15/20/15	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	21/20/21	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Third Quarter Ended September 30, 2019	21/19/21	CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Second Quarter Ended June 30, 2019	22/19/22	CI

Chart Ha Tay Pharmaceutical

Duration

Period

More charts

Company Profile

Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HA TAY PHARMACEUTICAL	+75.65%	13Cr
ELI LILLY AND COMPANY	+40.73%	74TCr
NOVO NORDISK A/S	+32.83%	60TCr
JOHNSON & JOHNSON	-6.30%	35TCr
MERCK & CO., INC.	+15.15%	32TCr
ABBVIE INC.	+4.05%	28TCr
ASTRAZENECA PLC	+15.00%	24TCr
NOVARTIS AG	+9.78%	21TCr
ROCHE HOLDING AG	-5.52%	21TCr
AMGEN INC.	+6.17%	16TCr

Other Pharmaceuticals